当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析 - 利润表

西藏药业

(600211)

  

流通市值:109.56亿  总市值:109.56亿
流通股本:2.48亿   总股本:2.48亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入3,134,328,350.182,368,009,918.391,820,236,994.97906,936,646.41
营业收入3,134,328,350.182,368,009,918.391,820,236,994.97906,936,646.41
二、营业总成本2,058,296,534.761,546,792,565.351,167,604,227.1579,955,616.95
营业成本155,084,807.26110,415,100.7176,481,826.3940,264,326.41
税金及附加38,167,538.4328,238,807.4321,391,449.2511,132,843.3
销售费用1,757,405,024.681,329,605,903.281,021,127,956.84506,805,922.67
管理费用124,000,698.1787,362,047.4153,974,364.7625,560,213.39
研发费用17,350,341.738,319,437.147,828,390.784,473,040.54
财务费用-33,711,875.51-17,148,730.62-13,199,760.92-8,280,729.36
其中:利息费用11,593,772.989,013,531.264,867,872.973,245,144.21
其中:利息收入45,779,084.1127,708,732.0918,871,390.2411,525,660.14
加:公允价值变动收益-210,533,170.37-2,676,343.06-2,444,374.39-2,063,065.42
加:投资收益40,442,161.9422,083,258.2517,057,176.7111,819,738.61
资产处置收益533,929.46-115,987.91-112,559.84-
资产减值损失(新)-193,969,778.73-3,122,221.83-3,121,819.78-
信用减值损失(新)-150,226.27-75,369.13-165,018.03643.39
其他收益186,738,221.85117,440,566.06615,128.0469,920.5
营业利润平衡项目0000
四、营业利润899,092,953.3954,751,255.42664,461,300.58336,808,266.54
加:营业外收入2,607,256.54727,125.275,158.16435,103.15
减:营业外支出3,505,382.9808,759.27300,252.29147,945.5
利润总额平衡项目0000
五、利润总额898,194,826.94954,669,621.35664,236,206.45337,095,424.19
减:所得税费用87,949,991.7191,149,532.9164,401,883.2831,580,317.68
六、净利润810,244,835.23863,520,088.44599,834,323.17305,515,106.51
持续经营净利润810,244,835.23863,520,088.44599,834,323.17305,515,106.51
归属于母公司股东的净利润800,913,981.92855,341,904.01595,904,757.58303,199,537.33
少数股东损益9,330,853.318,178,184.433,929,565.592,315,569.18
(一)基本每股收益3.233.452.41.22
(二)稀释每股收益3.233.452.41.22
八、其他综合收益18,235,579.0734,921,617.5441,662,632.6928,670,180
归属于母公司股东的其他综合收益18,235,579.0734,921,617.5441,662,632.6928,670,180
九、综合收益总额828,480,414.3898,441,705.98641,496,955.86334,185,286.51
归属于母公司股东的综合收益总额819,149,560.99890,263,521.55637,567,390.27331,869,717.33
归属于少数股东的综合收益总额9,330,853.318,178,184.433,929,565.592,315,569.18
公告日期2024-03-272023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑